• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间质干细胞与肺脏。

Mesenchymal stem cells and the lung.

机构信息

Queensland Lung Transplant Service, The Prince Charles Hospital, Brisbane, Queensland, Australia.

出版信息

Respirology. 2013 Apr;18(3):397-411. doi: 10.1111/resp.12050.

DOI:10.1111/resp.12050
PMID:23316733
Abstract

Mesenchymal stem cells (MSC) are a population of tissue-resident adult progenitor cells that were originally identified in bone marrow, but have now been identified in many organs including the lung. Although their precise role in organ function remains incompletely defined, mounting evidence suggests that they are an important component of the parenchymal progenitor cell niche and orchestrate organ homeostasis and repair following injury. In this review, what is known about MSC biology will be outlined with particular emphasis on lung biology, and the therapeutic potential of MSC-based cell therapy will also be highlighted.

摘要

间充质干细胞(MSC)是一种组织驻留的成体祖细胞群体,最初在骨髓中被鉴定出来,但现在已在许多器官中被鉴定出来,包括肺。尽管它们在器官功能中的确切作用仍不完全确定,但越来越多的证据表明,它们是实质祖细胞龛的重要组成部分,并在损伤后协调器官的稳态和修复。在这篇综述中,将概述 MSC 生物学的已知内容,特别强调肺生物学,并且还将突出基于 MSC 的细胞治疗的治疗潜力。

相似文献

1
Mesenchymal stem cells and the lung.间质干细胞与肺脏。
Respirology. 2013 Apr;18(3):397-411. doi: 10.1111/resp.12050.
2
Mesenchymal stem cell trials for pulmonary diseases.间充质干细胞治疗肺部疾病的试验
J Cell Biochem. 2014 Jun;115(6):1023-32. doi: 10.1002/jcb.24783.
3
Mesenchymal stem cell therapy for heart disease.间充质干细胞治疗心脏病。
Vascul Pharmacol. 2012 Aug 19;57(1):48-55. doi: 10.1016/j.vph.2012.04.002. Epub 2012 Apr 12.
4
Paracrine effects and heterogeneity of marrow-derived stem/progenitor cells: relevance for the treatment of respiratory diseases.旁分泌作用和骨髓源性干细胞/祖细胞的异质性:与呼吸系统疾病治疗的相关性。
Cells Tissues Organs. 2013;197(6):445-73. doi: 10.1159/000348831. Epub 2013 May 4.
5
The burden of lung disease: the need for stem cell therapy--a review series prologue.
Respirology. 2013 Apr;18(3):393-6. doi: 10.1111/resp.12057.
6
The potential of cell-based therapy in lung diseases.细胞疗法在肺部疾病中的潜力。
Expert Opin Biol Ther. 2013 Oct;13(10):1429-40. doi: 10.1517/14712598.2013.833603. Epub 2013 Aug 28.
7
Specific subsets of mesenchymal stroma cells to treat lung disorders--finding the Holy Grail.用于治疗肺部疾病的间充质基质细胞特定亚群——寻找圣杯。
Pulm Pharmacol Ther. 2014 Dec;29(2):93-5. doi: 10.1016/j.pupt.2014.08.001. Epub 2014 Sep 16.
8
Cell surface structures influence lung clearance rate of systemically infused mesenchymal stromal cells.细胞表面结构影响全身输注间充质基质细胞的肺部清除率。
Stem Cells. 2013 Feb;31(2):317-26. doi: 10.1002/stem.1271.
9
Role of bone marrow and mesenchymal stem cells in healing after traumatic injury.骨髓和间充质干细胞在创伤后愈合中的作用。
Surgery. 2013 Jan;153(1):44-51. doi: 10.1016/j.surg.2012.06.020. Epub 2012 Aug 3.
10
Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.人胚胎干细胞来源的间充质干细胞的细胞存活率和旁分泌能力提高,可提高肺动脉高压的治疗潜力。
Cell Transplant. 2012;21(10):2225-39. doi: 10.3727/096368912X653020. Epub 2012 Jul 5.

引用本文的文献

1
Role of mesenchymal stem cells in sepsis and their therapeutic potential in sepsis‑associated myopathy (Review).间充质干细胞在脓毒症中的作用及其在脓毒症相关性肌病中的治疗潜力(综述)。
Int J Mol Med. 2024 Nov;54(5). doi: 10.3892/ijmm.2024.5416. Epub 2024 Sep 2.
2
Artesunate Alleviates Chronic Hyperoxia-induced Bronchopulmonary Dysplasia by Suppressing NF-κB Pathway in Neonatal Mice.青蒿琥酯通过抑制 NF-κB 通路缓解新生小鼠慢性高氧诱导的支气管肺发育不良。
Comb Chem High Throughput Screen. 2024;27(18):2681-2690. doi: 10.2174/0113862073246710231002042239.
3
A systematic review of the research progress of traditional Chinese medicine against pulmonary fibrosis: from a pharmacological perspective.
从药理学角度对中医药抗肺纤维化研究进展的系统综述
Chin Med. 2023 Aug 3;18(1):96. doi: 10.1186/s13020-023-00797-7.
4
Skin-Derived ABCB5 Mesenchymal Stem Cells for High-Medical-Need Inflammatory Diseases: From Discovery to Entering Clinical Routine.皮肤源性 ABCB5 间充质干细胞治疗高医疗需求炎症性疾病:从发现到进入临床常规。
Int J Mol Sci. 2022 Dec 21;24(1):66. doi: 10.3390/ijms24010066.
5
The Restoring Effect of Human Umbilical Cord-Derived Mesenchymal Cell-Conditioned Medium (hMSC-CM) against Carbon Tetrachloride-Induced Pulmonary Fibrosis in Male Wistar Rats.人脐带间充质细胞条件培养基(hMSC-CM)对四氯化碳诱导的雄性Wistar大鼠肺纤维化的修复作用
Int J Inflam. 2022 Dec 22;2022:7179766. doi: 10.1155/2022/7179766. eCollection 2022.
6
The Emerging Role of Extracellular Vesicles from Mesenchymal Stem Cells and Macrophages in Pulmonary Fibrosis: Insights into miRNA Delivery.间充质干细胞和巨噬细胞来源的细胞外囊泡在肺纤维化中的新作用:对miRNA传递的见解
Pharmaceuticals (Basel). 2022 Oct 17;15(10):1276. doi: 10.3390/ph15101276.
7
Novel approaches for long-term lung transplant survival.用于长期肺移植存活的新方法。
Front Immunol. 2022 Jul 27;13:931251. doi: 10.3389/fimmu.2022.931251. eCollection 2022.
8
Perivascular Mesenchymal Stem/Stromal Cells, an Immune Privileged Niche for Viruses?血管周间充质干细胞,病毒的免疫特权生态位?
Int J Mol Sci. 2022 Jul 21;23(14):8038. doi: 10.3390/ijms23148038.
9
Placental mesenchymal stem cells boost M2 alveolar over M1 bone marrow macrophages via IL-1β in -mediated acute respiratory distress syndrome.胎盘间充质干细胞通过白细胞介素-1β促进 M2 肺泡巨噬细胞向 M1 骨髓巨噬细胞转化,从而引发急性呼吸窘迫综合征。
Thorax. 2023 May;78(5):504-514. doi: 10.1136/thoraxjnl-2021-217928. Epub 2022 Apr 21.
10
Mesenchymal Stromal Cells for the Treatment of Interstitial Lung Disease in Children: A Look from Pediatric and Pediatric Surgeon Viewpoints.间充质基质细胞治疗儿童间质性肺病:从儿科和小儿外科医生的观点看。
Cells. 2021 Nov 23;10(12):3270. doi: 10.3390/cells10123270.